How Much Does Mounjaro Cost in 2026?

Searching “how much does Mounjaro cost” usually turns up half a dozen different numbers, and they all look official. You are not imagining it: what Mounjaro costs depends on who is paying. Here is the clear breakdown, with every figure tied to a named source and a date, because GLP-1 pricing has changed more than once in the past year and any article without dates is already out of step.

Every figure below is as of 2026. Start with the direct question and the highest number, the one almost nobody actually pays.

Mounjaro’s 2026 list price

With no insurance and no program applied, Mounjaro sits near its list price. The list price (what Lilly charges wholesalers) runs about $1,080 a month, according to Lilly’s pricing information. But the number you actually see at the counter tends to be higher: GoodRx puts the average retail price at about $1,347 a month for the most common version, with data updated in June 2026.

That most common version is a carton of four single-dose pens, one for each week of the month. With a GoodRx coupon, the same carton drops to roughly $1,096 a month, about 19% below the average retail price. Mounjaro also comes in vials in addition to the pens, and there is no approved generic.

It helps to understand what the list price is and is not. It is the starting point for negotiations among the manufacturer, insurers, and pharmacy benefit managers, not what most people hand over at the counter. We include it because it is the number a pharmacy rings up when Mounjaro is processed with no program and no coverage applied, and because it sets the baseline for measuring how much each savings route cuts off.

What affects Mounjaro’s price

The price you actually pay is a function of three things: whether you use insurance, which manufacturer program applies, and which dose you are on.

The first matters more than any other factor. Mounjaro is FDA-approved for type 2 diabetes, not for weight loss. Tirzepatide, its active ingredient, is also sold under a second brand, Zepbound, which is the version approved for weight management. That distinction changes the insurance conversation entirely: a plan that covers Mounjaro does so for the diabetes indication, almost always with prior authorization, meaning your clinician has to document that you meet the criteria before the insurer pays. A plan will not cover Mounjaro “for weight loss,” because that is not its indication. GLP-1 medications are FDA-approved for specific indications, and eligibility is determined by a licensed clinician.

The second factor is the manufacturer program. The Mounjaro Savings Card can cut the cost sharply, but only for a certain patient profile, and with caps. More on that in the next section.

The third, your dose, matters less than people expect with Mounjaro: unlike some products, the list and retail prices are similar across the different strengths. What does change over time is your maintenance dose, because a typical plan titrates up over several weeks. Budget for the long-term cost, not just the first fill.

Cash-pay options and lower-cost routes

If you are paying out of pocket, you are not stuck with the list price. These are the published 2026 routes for brand-name Mounjaro:

Route	Price (4-week supply)	Source
Pharmacy, no program	near list price, ~$1,347 average	GoodRx
GoodRx coupon	from ~$1,096 a month	GoodRx
Savings Card (commercial insurance without Mounjaro coverage)	as little as $499 a month	Mounjaro Savings & Coverage
Savings Card (commercial insurance with Mounjaro coverage)	as little as $25 for up to a 3-month fill	Mounjaro Savings & Coverage

Two details are worth pinning down. First, the Savings Card has caps: for people with commercial insurance that does not cover Mounjaro, the maximum monthly savings is about $647 and the annual maximum about $8,411, with up to 13 fills a year, and the card expires December 31, 2026, per Lilly. Second, people on government insurance (Medicare, Medicaid, TRICARE, VA, or DoD) are not eligible for the manufacturer card. For those cases, Lilly points to the Medicare Prescription Payment Plan (M3P) as a tool to spread the cost across fixed monthly payments over the year, not to reduce it.

For people without insurance, Lilly also offers self-pay Mounjaro through LillyDirect, with a prescription required. It is a way to buy the brand product, not a discount: the price is still the manufacturer’s self-pay number.

There is also a different route. Rather than decoding formularies and authorization letters, many people choose a telehealth program with transparent pricing, where the value is the care around the prescription. REMEVi sits in that group: a physician-led team reviews your health history and eligibility before anything is prescribed, REMEVi’s transparent pricing means the number you see up front is the number you pay with no insurance call and no prior-authorization wait, medications ship from NPI-verified US pharmacies, and a care coordinator checks in through the early dose-adjustment weeks when questions actually come up.

Some telehealth programs, REMEVi included, work with compounded tirzepatide when a licensed provider determines it is appropriate for the individual patient. It is worth being exact about what that means. Compounded tirzepatide is a non-FDA-approved preparation prepared by a state-licensed US compounding pharmacy under an individual prescription from a licensed provider. It is not a generic version of, and is not the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Compounded preparations have not been clinically studied as finished products. A licensed clinician should walk you through that distinction before you choose either route.

Mounjaro, Zepbound, and tirzepatide: don’t mix them up

This is the most common point of confusion about price, so it is worth clearing up. Mounjaro and Zepbound share the same molecule, tirzepatide, and the same manufacturer, Eli Lilly. What differs is the FDA approval: Mounjaro is approved to improve blood sugar control in adults with type 2 diabetes, while Zepbound is the brand approved for chronic weight management.

That difference in indication, per the FDA, is why each brand’s insurance coverage and savings programs work separately, even though the active ingredient inside is the same. If your goal is weight management, the conversation with your clinician is likely to center on Zepbound or tirzepatide in general, not Mounjaro. And to see how tirzepatide compares with the other major family of these medications, read our guide to semaglutide vs tirzepatide.

The same pricing logic applies across the GLP-1 family: the number you pay depends on your prescription’s indication, your plan’s formulary, and your eligibility for manufacturer programs. For the parallel case with brand-name semaglutide, see how much Wegovy costs.

The bottom line

As of 2026, Mounjaro’s list price is about $1,080 a month and the average retail cash price without insurance is near $1,347, though almost nobody pays the full number. A GoodRx coupon brings it close to $1,096; the manufacturer’s Savings Card can bring it to as little as $499 a month for certain commercially insured patients, or $25 for up to a three-month fill if the plan covers Mounjaro. Remember that Mounjaro is approved for type 2 diabetes, not weight loss, and that the caps and eligibility rules change who pays what. The right move is to confirm your indication, your plan’s answer, and your long-term maintenance-dose cost before you commit to any route.

If you would rather have a clinician walk you through it than decode formularies alone, that is what we are here for. Your Health. Your Terms. Real doctors. Real care. remevihealth.com

---

This article is for general information and does not constitute medical advice. GLP-1 medications are FDA-approved for specific indications, and eligibility is determined by a licensed clinician. Compounded tirzepatide is a non-FDA-approved preparation prepared by a state-licensed US compounding pharmacy under an individual prescription from a licensed provider. It is not a generic version of, and is not the same as, Ozempic®, Wegovy®, Mounjaro®, or Zepbound®. Compounded preparations have not been clinically studied as finished products. Prices cited are as of 2026, come from the named sources, and are subject to change without notice. Consult a licensed provider before starting any prescription treatment.